speb/financial-data huggingface dataset:
CGEN balance_sheet (annual, 2023-12-31) — Capital Lease Obligations: 1351000.00
CGEN balance_sheet (annual, 2023-12-31) — Capital Stock: 247000.00
CGEN balance_sheet (annual, 2023-12-31) — Cash And Cash Equivalents: 13890000.00
CGEN balance_sheet (annual, 2023-12-31) — Cash Cash Equivalents And Short Term Investments: 50685000.00
CGEN cash_flow (annual, 2023-12-31) — Cash Flow From Continuing Financing Activities: 3081000.00
CGEN cash_flow (annual, 2023-12-31) — Cash Flow From Continuing Investing Activities: 35510000.00
CGEN cash_flow (annual, 2023-12-31) — Cash Flow From Continuing Operating Activities: -35886000.00
CGEN cash_flow (annual, 2023-12-31) — Change In Account Payable: 1734000.00
CGEN cash_flow (annual, 2023-12-31) — Change In Accrued Expense: 1462000.00
CGEN cash_flow (annual, 2023-12-31) — Change In Other Current Assets: 568000.00
CGEN cash_flow (annual, 2023-12-31) — Change In Other Current Liabilities: -645000.00
CGEN cash_flow (annual, 2023-12-31) — Change In Other Working Capital: 36529000.00
CGEN cash_flow (annual, 2023-12-31) — Change In Payable: 1734000.00
CGEN cash_flow (annual, 2023-12-31) — Change In Payables And Accrued Expense: 3196000.00
CGEN cash_flow (annual, 2023-12-31) — Change In Prepaid Assets: 666000.00
CGEN cash_flow (annual, 2023-12-31) — Change In Receivables: -61020000.00
CGEN cash_flow (annual, 2023-12-31) — Change In Working Capital: -20706000.00
CGEN cash_flow (annual, 2023-12-31) — Changes In Account Receivables: -61000000.00
CGEN cash_flow (annual, 2023-12-31) — Changes In Cash: 2705000.00
CGEN balance_sheet (annual, 2023-12-31) — Common Stock: 247000.00
CGEN balance_sheet (annual, 2023-12-31) — Common Stock Equity: 65559000.00
CGEN cash_flow (annual, 2023-12-31) — Common Stock Issuance: 3081000.00
CGEN income_statement (annual, 2023-12-31) — Cost Of Revenue: 2004000.00
CGEN balance_sheet (annual, 2023-12-31) — Current Accrued Expenses: 7858000.00
CGEN balance_sheet (annual, 2023-12-31) — Current Assets: 114579000.00
CGEN balance_sheet (annual, 2023-12-31) — Current Capital Lease Obligation: 632000.00
CGEN balance_sheet (annual, 2023-12-31) — Current Debt And Capital Lease Obligation: 632000.00
CGEN balance_sheet (annual, 2023-12-31) — Current Deferred Liabilities: 11149000.00
CGEN balance_sheet (annual, 2023-12-31) — Current Deferred Revenue: 11149000.00
CGEN balance_sheet (annual, 2023-12-31) — Current Liabilities: 26266000.00
CGEN balance_sheet (annual, 2023-12-31) — Defined Pension Benefit: 2977000.00
CGEN cash_flow (annual, 2023-12-31) — Depreciation: 476000.00
CGEN cash_flow (annual, 2023-12-31) — Depreciation Amortization Depletion: 476000.00
CGEN cash_flow (annual, 2023-12-31) — Depreciation And Amortization: 476000.00
CGEN income_statement (annual, 2023-12-31) — Diluted Average Shares: 87633298.00
CGEN income_statement (annual, 2023-12-31) — Diluted EPS: -0.21
CGEN income_statement (annual, 2023-12-31) — Diluted NI Availto Com Stockholders: -18754000.00
CGEN income_statement (annual, 2023-12-31) — EBIT: -12992000.00
CGEN income_statement (annual, 2023-12-31) — EBITDA: -12516000.00
CGEN cash_flow (annual, 2023-12-31) — Effect Of Exchange Rate Changes: 129000.00
CGEN balance_sheet (annual, 2023-12-31) — Employee Benefits: 3398000.00
CGEN cash_flow (annual, 2023-12-31) — End Cash Position: 14255000.00
CGEN cash_flow (annual, 2023-12-31) — Financing Cash Flow: 3081000.00
CGEN cash_flow (annual, 2023-12-31) — Free Cash Flow: -36058000.00
CGEN cash_flow (annual, 2023-12-31) — Gain Loss On Sale Of PPE: 7000.00
CGEN income_statement (annual, 2023-12-31) — Gain On Sale Of Ppe: -7000.00
CGEN income_statement (annual, 2023-12-31) — Gain On Sale Of Security: 5000.00
CGEN balance_sheet (annual, 2023-12-31) — Gains Losses Not Affecting Retained Earnings: 2000.00
CGEN income_statement (annual, 2023-12-31) — General And Administrative Expense: 9731000.00
CGEN balance_sheet (annual, 2023-12-31) — Gross PPE: 7901000.00
CGEN income_statement (annual, 2023-12-31) — Gross Profit: 31455000.00
CGEN cash_flow (annual, 2023-12-31) — Income Tax Paid Supplemental Data: 12000.00
CGEN income_statement (annual, 2023-12-31) — Interest Income: 3241000.00
CGEN income_statement (annual, 2023-12-31) — Interest Income Non Operating: 3241000.00
CGEN cash_flow (annual, 2023-12-31) — Interest Paid Supplemental Data: 3052000.00
CGEN balance_sheet (annual, 2023-12-31) — Invested Capital: 65559000.00
CGEN cash_flow (annual, 2023-12-31) — Investing Cash Flow: 35510000.00
CGEN cash_flow (annual, 2023-12-31) — Issuance Of Capital Stock: 3081000.00
CGEN balance_sheet (annual, 2023-12-31) — Leases: 2314000.00
CGEN balance_sheet (annual, 2023-12-31) — Long Term Capital Lease Obligation: 719000.00
CGEN balance_sheet (annual, 2023-12-31) — Long Term Debt And Capital Lease Obligation: 719000.00
CGEN balance_sheet (annual, 2023-12-31) — Machinery Furniture Equipment: 4258000.00
CGEN cash_flow (annual, 2023-12-31) — Net Common Stock Issuance: 3081000.00
CGEN cash_flow (annual, 2023-12-31) — Net Foreign Currency Exchange Gain Loss: -129000.00
CGEN income_statement (annual, 2023-12-31) — Net Income: -18754000.00
CGEN income_statement (annual, 2023-12-31) — Net Income Common Stockholders: -18754000.00
CGEN income_statement (annual, 2023-12-31) — Net Income Continuous Operations: -18754000.00
CGEN income_statement (annual, 2023-12-31) — Net Income From Continuing And Discontinued Operation: -18754000.00
CGEN income_statement (annual, 2023-12-31) — Net Income From Continuing Operation Net Minority Interest: -18754000.00
CGEN cash_flow (annual, 2023-12-31) — Net Income From Continuing Operations: -18754000.00
CGEN income_statement (annual, 2023-12-31) — Net Income Including Noncontrolling Interests: -18754000.00
CGEN income_statement (annual, 2023-12-31) — Net Interest Income: 3210000.00
CGEN cash_flow (annual, 2023-12-31) — Net Investment Purchase And Sale: 35682000.00
CGEN income_statement (annual, 2023-12-31) — Net Non Operating Interest Income Expense: 3210000.00
CGEN balance_sheet (annual, 2023-12-31) — Net PPE: 2545000.00
CGEN cash_flow (annual, 2023-12-31) — Net PPE Purchase And Sale: -172000.00
CGEN balance_sheet (annual, 2023-12-31) — Net Tangible Assets: 65559000.00
CGEN balance_sheet (annual, 2023-12-31) — Non Current Deferred Liabilities: 25392000.00
CGEN balance_sheet (annual, 2023-12-31) — Non Current Deferred Revenue: 25392000.00
CGEN balance_sheet (annual, 2023-12-31) — Non Current Pension And Other Postretirement Benefit Plans: 3398000.00
CGEN balance_sheet (annual, 2023-12-31) — Non Current Prepaid Assets: 1233000.00
CGEN income_statement (annual, 2023-12-31) — Normalized EBITDA: -12514000.00
CGEN income_statement (annual, 2023-12-31) — Normalized Income: -18752460.00
CGEN cash_flow (annual, 2023-12-31) — Operating Cash Flow: -35886000.00
CGEN cash_flow (annual, 2023-12-31) — Operating Gains Losses: -172000.00
CGEN income_statement (annual, 2023-12-31) — Operating Income: -12992000.00
CGEN income_statement (annual, 2023-12-31) — Operating Revenue: 33459000.00
CGEN balance_sheet (annual, 2023-12-31) — Ordinary Shares Number: 89237465.00
CGEN balance_sheet (annual, 2023-12-31) — Other Equity Adjustments: 2000.00
CGEN income_statement (annual, 2023-12-31) — Other Gand A: 9731000.00
CGEN income_statement (annual, 2023-12-31) — Other Income Expense: -2000.00
CGEN cash_flow (annual, 2023-12-31) — Other Non Cash Items: -280000.00
CGEN balance_sheet (annual, 2023-12-31) — Other Properties: 1329000.00
CGEN balance_sheet (annual, 2023-12-31) — Other Receivables: 318000.00
CGEN balance_sheet (annual, 2023-12-31) — Other Short Term Investments: 36795000.00
CGEN balance_sheet (annual, 2023-12-31) — Payables: 3502000.00
CGEN balance_sheet (annual, 2023-12-31) — Payables And Accrued Expenses: 11360000.00
CGEN cash_flow (annual, 2023-12-31) — Pension And Employee Benefit Expense: -50000.00
CGEN balance_sheet (annual, 2023-12-31) — Pensionand Other Post Retirement Benefit Plans Current: 3125000.00
CGEN balance_sheet (annual, 2023-12-31) — Prepaid Assets: 2211000.00
CGEN income_statement (annual, 2023-12-31) — Pretax Income: -9784000.00
CGEN cash_flow (annual, 2023-12-31) — Proceeds From Stock Option Exercised: 0.00
CGEN balance_sheet (annual, 2023-12-31) — Properties: 0.00
CGEN cash_flow (annual, 2023-12-31) — Purchase Of Investment: -53705000.00
CGEN cash_flow (annual, 2023-12-31) — Purchase Of PPE: -172000.00
CGEN balance_sheet (annual, 2023-12-31) — Receivables: 61318000.00
CGEN income_statement (annual, 2023-12-31) — Reconciled Cost Of Revenue: 2004000.00
CGEN income_statement (annual, 2023-12-31) — Reconciled Depreciation: 476000.00
CGEN income_statement (annual, 2023-12-31) — Research And Development: 34472000.00
CGEN balance_sheet (annual, 2023-12-31) — Restricted Cash: 365000.00
CGEN balance_sheet (annual, 2023-12-31) — Retained Earnings: -474527000.00
CGEN cash_flow (annual, 2023-12-31) — Sale Of Investment: 89387000.00
CGEN cash_flow (annual, 2023-12-31) — Sale Of PPE: 0.00
CGEN income_statement (annual, 2023-12-31) — Selling And Marketing Expense: 244000.00
CGEN income_statement (annual, 2023-12-31) — Selling General And Administration: 9975000.00
CGEN balance_sheet (annual, 2023-12-31) — Share Issued: 89237465.00
CGEN income_statement (annual, 2023-12-31) — Special Income Charges: -7000.00
CGEN cash_flow (annual, 2023-12-31) — Stock Based Compensation: 3550000.00
CGEN balance_sheet (annual, 2023-12-31) — Stockholders Equity: 65559000.00
CGEN balance_sheet (annual, 2023-12-31) — Tangible Book Value: 65559000.00
CGEN income_statement (annual, 2023-12-31) — Tax Effect Of Unusual Items: -460.00
CGEN income_statement (annual, 2023-12-31) — Tax Provision: 8970000.00
CGEN income_statement (annual, 2023-12-31) — Tax Rate For Calcs: 0.23
CGEN balance_sheet (annual, 2023-12-31) — Total Assets: 121334000.00
CGEN balance_sheet (annual, 2023-12-31) — Total Capitalization: 65559000.00
CGEN balance_sheet (annual, 2023-12-31) — Total Debt: 1351000.00
CGEN balance_sheet (annual, 2023-12-31) — Total Equity Gross Minority Interest: 65559000.00
CGEN income_statement (annual, 2023-12-31) — Total Expenses: 46451000.00
CGEN balance_sheet (annual, 2023-12-31) — Total Liabilities Net Minority Interest: 55775000.00
CGEN balance_sheet (annual, 2023-12-31) — Total Non Current Assets: 6755000.00
CGEN balance_sheet (annual, 2023-12-31) — Total Non Current Liabilities Net Minority Interest: 29509000.00
CGEN income_statement (annual, 2023-12-31) — Total Operating Income As Reported: -12992000.00
CGEN income_statement (annual, 2023-12-31) — Total Other Finance Cost: 31000.00
CGEN income_statement (annual, 2023-12-31) — Total Unusual Items: -2000.00
CGEN income_statement (annual, 2023-12-31) — Total Unusual Items Excluding Goodwill: -2000.00
CGEN balance_sheet (annual, 2023-12-31) — Treasury Shares Number: 0.00
CGEN balance_sheet (annual, 2023-12-31) — Working Capital: 88313000.00
CGEN balance_sheet (quarterly, 2024-09-30) — Accounts Receivable: 0.00
CGEN income_statement (quarterly, 2024-09-30) — Interest Income: 1284000.00
CGEN income_statement (quarterly, 2024-09-30) — Interest Income Non Operating: 1284000.00
CGEN balance_sheet (quarterly, 2024-09-30) — Restricted Cash: 0.00
CGEN income_statement (annual, 2024-12-31) — +Operating Expense: 34825000.00
CGEN income_statement (annual, 2024-12-31) — +Total Revenue: 27864000.00
CGEN balance_sheet (annual, 2024-12-31) — Accounts Payable: 1838000.00
CGEN balance_sheet (quarterly, 2024-12-31) — Accounts Payable: 1838000.00
CGEN balance_sheet (annual, 2024-12-31) — Accounts Receivable: 0.00
CGEN balance_sheet (quarterly, 2024-12-31) — Accounts Receivable: 0.00
CGEN balance_sheet (annual, 2024-12-31) — Accumulated Depreciation: -5748000.00
CGEN balance_sheet (quarterly, 2024-12-31) — Accumulated Depreciation: -5748000.00
CGEN balance_sheet (annual, 2024-12-31) — Additional Paid In Capital: 543413000.00
CGEN balance_sheet (quarterly, 2024-12-31) — Additional Paid In Capital: 543413000.00
CGEN income_statement (annual, 2024-12-31) — Basic Average Shares: 89528031.00
CGEN income_statement (annual, 2024-12-31) — Basic EPS: -0.16
CGEN cash_flow (annual, 2024-12-31) — Beginning Cash Position: 14255000.00
CGEN cash_flow (annual, 2024-12-31) — Capital Expenditure: -118000.00
CGEN balance_sheet (annual, 2024-12-31) — Capital Lease Obligations: 2912000.00
CGEN balance_sheet (annual, 2024-12-31) — Capital Stock: 248000.00
CGEN balance_sheet (quarterly, 2024-12-31) — Capital Stock: 248000.00
CGEN balance_sheet (annual, 2024-12-31) — Cash And Cash Equivalents: 18229000.00
CGEN balance_sheet (annual, 2024-12-31) — Cash Cash Equivalents And Short Term Investments: 103255000.00
CGEN cash_flow (annual, 2024-12-31) — Cash Flow From Continuing Financing Activities: 554000.00
CGEN cash_flow (annual, 2024-12-31) — Cash Flow From Continuing Investing Activities: -46252000.00
CGEN cash_flow (annual, 2024-12-31) — Cash Flow From Continuing Operating Activities: 49604000.00
CGEN cash_flow (annual, 2024-12-31) — Change In Account Payable: -1669000.00
CGEN cash_flow (annual, 2024-12-31) — Change In Accrued Expense: -2690000.00
CGEN cash_flow (annual, 2024-12-31) — Change In Other Current Assets: 550000.00
CGEN cash_flow (annual, 2024-12-31) — Change In Other Current Liabilities: -503000.00
CGEN cash_flow (annual, 2024-12-31) — Change In Other Working Capital: 7085000.00
CGEN cash_flow (annual, 2024-12-31) — Change In Payable: -1669000.00
CGEN cash_flow (annual, 2024-12-31) — Change In Payables And Accrued Expense: -4359000.00
CGEN cash_flow (annual, 2024-12-31) — Change In Prepaid Assets: -655000.00
CGEN cash_flow (annual, 2024-12-31) — Change In Receivables: 59932000.00
CGEN cash_flow (annual, 2024-12-31) — Change In Working Capital: 62050000.00
CGEN cash_flow (annual, 2024-12-31) — Changes In Account Receivables: 61000000.00
CGEN cash_flow (annual, 2024-12-31) — Changes In Cash: 3906000.00
CGEN balance_sheet (annual, 2024-12-31) — Common Stock: 248000.00
CGEN balance_sheet (quarterly, 2024-12-31) — Common Stock: 248000.00
CGEN balance_sheet (annual, 2024-12-31) — Common Stock Equity: 54914000.00
CGEN cash_flow (annual, 2024-12-31) — Common Stock Issuance: 544000.00
CGEN income_statement (annual, 2024-12-31) — Cost Of Revenue: 7930000.00
CGEN balance_sheet (annual, 2024-12-31) — Current Accrued Expenses: 5168000.00
CGEN balance_sheet (quarterly, 2024-12-31) — Current Accrued Expenses: 5168000.00
CGEN balance_sheet (annual, 2024-12-31) — Current Assets: 105997000.00
CGEN balance_sheet (annual, 2024-12-31) — Current Capital Lease Obligation: 448000.00
CGEN balance_sheet (annual, 2024-12-31) — Current Debt And Capital Lease Obligation: 448000.00
CGEN balance_sheet (annual, 2024-12-31) — Current Deferred Liabilities: 9632000.00
CGEN balance_sheet (annual, 2024-12-31) — Current Deferred Revenue: 9632000.00
CGEN balance_sheet (annual, 2024-12-31) — Current Liabilities: 20160000.00
CGEN balance_sheet (annual, 2024-12-31) — Defined Pension Benefit: 3072000.00
CGEN cash_flow (annual, 2024-12-31) — Depreciation: 486000.00
CGEN cash_flow (annual, 2024-12-31) — Depreciation Amortization Depletion: 486000.00
CGEN cash_flow (annual, 2024-12-31) — Depreciation And Amortization: 486000.00
CGEN income_statement (annual, 2024-12-31) — Diluted Average Shares: 89528031.00
CGEN income_statement (annual, 2024-12-31) — Diluted EPS: -0.16
CGEN income_statement (annual, 2024-12-31) — Diluted NI Availto Com Stockholders: -14231000.00
CGEN income_statement (annual, 2024-12-31) — EBIT: -14891000.00
CGEN income_statement (annual, 2024-12-31) — EBITDA: -14405000.00
CGEN cash_flow (annual, 2024-12-31) — Effect Of Exchange Rate Changes: 68000.00
CGEN balance_sheet (annual, 2024-12-31) — Employee Benefits: 3412000.00
CGEN cash_flow (annual, 2024-12-31) — End Cash Position: 18229000.00
CGEN cash_flow (annual, 2024-12-31) — Financing Cash Flow: 554000.00
CGEN cash_flow (annual, 2024-12-31) — Free Cash Flow: 49486000.00
CGEN cash_flow (annual, 2024-12-31) — Gain Loss On Sale Of PPE: 0.00
CGEN income_statement (annual, 2024-12-31) — Gain On Sale Of Ppe: 0.00
CGEN income_statement (annual, 2024-12-31) — Gain On Sale Of Security: -20000.00
CGEN balance_sheet (annual, 2024-12-31) — Gains Losses Not Affecting Retained Earnings: 11000.00
CGEN balance_sheet (quarterly, 2024-12-31) — Gains Losses Not Affecting Retained Earnings: 11000.00
CGEN income_statement (annual, 2024-12-31) — General And Administrative Expense: 9439000.00
CGEN balance_sheet (annual, 2024-12-31) — Gross PPE: 9443000.00
CGEN income_statement (annual, 2024-12-31) — Gross Profit: 19934000.00
CGEN cash_flow (annual, 2024-12-31) — Income Tax Paid Supplemental Data: 13517000.00
CGEN income_statement (annual, 2024-12-31) — Interest Income: 5236000.00
CGEN income_statement (quarterly, 2024-12-31) — Interest Income: 1424000.00
CGEN income_statement (annual, 2024-12-31) — Interest Income Non Operating: 5236000.00
CGEN income_statement (quarterly, 2024-12-31) — Interest Income Non Operating: 1424000.00
CGEN balance_sheet (annual, 2024-12-31) — Invested Capital: 54914000.00
CGEN balance_sheet (quarterly, 2024-12-31) — Invested Capital: 54914000.00
CGEN cash_flow (annual, 2024-12-31) — Investing Cash Flow: -46252000.00
CGEN cash_flow (annual, 2024-12-31) — Issuance Of Capital Stock: 544000.00
CGEN balance_sheet (annual, 2024-12-31) — Leases: 2314000.00
CGEN balance_sheet (quarterly, 2024-12-31) — Leases: 2314000.00
CGEN balance_sheet (annual, 2024-12-31) — Long Term Capital Lease Obligation: 2464000.00
CGEN balance_sheet (annual, 2024-12-31) — Long Term Debt And Capital Lease Obligation: 2464000.00
CGEN balance_sheet (annual, 2024-12-31) — Machinery Furniture Equipment: 4286000.00
CGEN balance_sheet (quarterly, 2024-12-31) — Machinery Furniture Equipment: 4286000.00
CGEN cash_flow (annual, 2024-12-31) — Net Common Stock Issuance: 544000.00
CGEN cash_flow (annual, 2024-12-31) — Net Foreign Currency Exchange Gain Loss: -68000.00
CGEN income_statement (annual, 2024-12-31) — Net Income: -14231000.00
CGEN income_statement (annual, 2024-12-31) — Net Income Common Stockholders: -14231000.00
CGEN income_statement (annual, 2024-12-31) — Net Income Continuous Operations: -14231000.00
CGEN income_statement (annual, 2024-12-31) — Net Income From Continuing And Discontinued Operation: -14231000.00
CGEN income_statement (annual, 2024-12-31) — Net Income From Continuing Operation Net Minority Interest: -14231000.00
CGEN cash_flow (annual, 2024-12-31) — Net Income From Continuing Operations: -14231000.00
CGEN income_statement (annual, 2024-12-31) — Net Income Including Noncontrolling Interests: -14231000.00
CGEN income_statement (annual, 2024-12-31) — Net Interest Income: 5202000.00
CGEN cash_flow (annual, 2024-12-31) — Net Investment Purchase And Sale: -45805000.00
CGEN income_statement (annual, 2024-12-31) — Net Non Operating Interest Income Expense: 5202000.00
CGEN cash_flow (annual, 2024-12-31) — Net Other Investing Changes: -330000.00
CGEN balance_sheet (annual, 2024-12-31) — Net PPE: 3695000.00
CGEN cash_flow (annual, 2024-12-31) — Net PPE Purchase And Sale: -117000.00
CGEN balance_sheet (annual, 2024-12-31) — Net Tangible Assets: 54914000.00
CGEN balance_sheet (annual, 2024-12-31) — Non Current Deferred Liabilities: 34045000.00
CGEN balance_sheet (annual, 2024-12-31) — Non Current Deferred Revenue: 34045000.00
CGEN balance_sheet (annual, 2024-12-31) — Non Current Pension And Other Postretirement Benefit Plans: 3412000.00
CGEN balance_sheet (annual, 2024-12-31) — Non Current Prepaid Assets: 1888000.00
CGEN income_statement (annual, 2024-12-31) — Normalized EBITDA: -14385000.00
CGEN income_statement (annual, 2024-12-31) — Normalized Income: -14215600.00
CGEN cash_flow (annual, 2024-12-31) — Operating Cash Flow: 49604000.00
CGEN cash_flow (annual, 2024-12-31) — Operating Gains Losses: -149000.00
CGEN income_statement (annual, 2024-12-31) — Operating Income: -14891000.00
CGEN income_statement (annual, 2024-12-31) — Operating Revenue: 27864000.00
CGEN balance_sheet (annual, 2024-12-31) — Ordinary Shares Number: 89541246.00
CGEN balance_sheet (annual, 2024-12-31) — Other Equity Adjustments: 11000.00
CGEN balance_sheet (quarterly, 2024-12-31) — Other Equity Adjustments: 11000.00
CGEN income_statement (annual, 2024-12-31) — Other Gand A: 9439000.00
CGEN income_statement (annual, 2024-12-31) — Other Income Expense: -20000.00
CGEN cash_flow (annual, 2024-12-31) — Other Non Cash Items: -1575000.00
CGEN balance_sheet (annual, 2024-12-31) — Other Non Current Assets: 343000.00
CGEN balance_sheet (annual, 2024-12-31) — Other Properties: 2843000.00
CGEN balance_sheet (annual, 2024-12-31) — Other Receivables: 269000.00
CGEN balance_sheet (annual, 2024-12-31) — Other Short Term Investments: 85026000.00
CGEN balance_sheet (annual, 2024-12-31) — Payables: 1838000.00
CGEN balance_sheet (quarterly, 2024-12-31) — Payables: 1838000.00
CGEN balance_sheet (annual, 2024-12-31) — Payables And Accrued Expenses: 7006000.00
CGEN cash_flow (annual, 2024-12-31) — Pension And Employee Benefit Expense: -81000.00
CGEN balance_sheet (annual, 2024-12-31) — Pensionand Other Post Retirement Benefit Plans Current: 3074000.00
CGEN balance_sheet (quarterly, 2024-12-31) — Pensionand Other Post Retirement Benefit Plans Current: 3074000.00
CGEN balance_sheet (annual, 2024-12-31) — Prepaid Assets: 2473000.00
CGEN balance_sheet (quarterly, 2024-12-31) — Prepaid Assets: 2473000.00
CGEN income_statement (annual, 2024-12-31) — Pretax Income: -9709000.00
CGEN cash_flow (annual, 2024-12-31) — Proceeds From Stock Option Exercised: 10000.00
CGEN balance_sheet (annual, 2024-12-31) — Properties: 0.00
CGEN balance_sheet (quarterly, 2024-12-31) — Properties: 0.00
CGEN cash_flow (annual, 2024-12-31) — Purchase Of Investment: -159752000.00
CGEN cash_flow (annual, 2024-12-31) — Purchase Of PPE: -118000.00
CGEN balance_sheet (annual, 2024-12-31) — Receivables: 269000.00
CGEN income_statement (annual, 2024-12-31) — Reconciled Cost Of Revenue: 7930000.00
CGEN income_statement (annual, 2024-12-31) — Reconciled Depreciation: 486000.00
CGEN income_statement (annual, 2024-12-31) — Research And Development: 24810000.00
CGEN balance_sheet (annual, 2024-12-31) — Restricted Cash: 0.00
CGEN balance_sheet (quarterly, 2024-12-31) — Restricted Cash: 0.00
CGEN balance_sheet (annual, 2024-12-31) — Retained Earnings: -488758000.00
CGEN balance_sheet (quarterly, 2024-12-31) — Retained Earnings: -488758000.00
CGEN cash_flow (annual, 2024-12-31) — Sale Of Investment: 113947000.00
CGEN cash_flow (annual, 2024-12-31) — Sale Of PPE: 1000.00
CGEN income_statement (annual, 2024-12-31) — Selling And Marketing Expense: 576000.00
CGEN income_statement (annual, 2024-12-31) — Selling General And Administration: 10015000.00
CGEN balance_sheet (annual, 2024-12-31) — Share Issued: 89541246.00
CGEN income_statement (annual, 2024-12-31) — Special Income Charges: 0.00
CGEN cash_flow (annual, 2024-12-31) — Stock Based Compensation: 3023000.00
CGEN balance_sheet (annual, 2024-12-31) — Stockholders Equity: 54914000.00
CGEN balance_sheet (annual, 2024-12-31) — Tangible Book Value: 54914000.00
CGEN income_statement (annual, 2024-12-31) — Tax Effect Of Unusual Items: -4600.00
CGEN income_statement (annual, 2024-12-31) — Tax Provision: 4522000.00
CGEN income_statement (annual, 2024-12-31) — Tax Rate For Calcs: 0.23
CGEN balance_sheet (annual, 2024-12-31) — Total Assets: 114995000.00
CGEN balance_sheet (annual, 2024-12-31) — Total Capitalization: 54914000.00
CGEN balance_sheet (annual, 2024-12-31) — Total Debt: 2912000.00
CGEN balance_sheet (annual, 2024-12-31) — Total Equity Gross Minority Interest: 54914000.00
CGEN income_statement (annual, 2024-12-31) — Total Expenses: 42755000.00
CGEN balance_sheet (annual, 2024-12-31) — Total Liabilities Net Minority Interest: 60081000.00
CGEN balance_sheet (annual, 2024-12-31) — Total Non Current Assets: 8998000.00
CGEN balance_sheet (annual, 2024-12-31) — Total Non Current Liabilities Net Minority Interest: 39921000.00
CGEN income_statement (annual, 2024-12-31) — Total Operating Income As Reported: -14891000.00
CGEN income_statement (annual, 2024-12-31) — Total Other Finance Cost: 34000.00
CGEN income_statement (annual, 2024-12-31) — Total Unusual Items: -20000.00
CGEN income_statement (annual, 2024-12-31) — Total Unusual Items Excluding Goodwill: -20000.00
CGEN balance_sheet (annual, 2024-12-31) — Working Capital: 85837000.00
CGEN income_statement (quarterly, 2025-03-31) — +Operating Expense: 8279000.00
CGEN income_statement (quarterly, 2025-03-31) — +Total Revenue: 2284000.00
CGEN income_statement (quarterly, 2025-03-31) — Basic Average Shares: 92308225.00
CGEN income_statement (quarterly, 2025-03-31) — Basic EPS: -0.08
CGEN balance_sheet (quarterly, 2025-03-31) — Capital Lease Obligations: 2771000.00
CGEN balance_sheet (quarterly, 2025-03-31) — Cash And Cash Equivalents: 14575000.00
CGEN balance_sheet (quarterly, 2025-03-31) — Cash Cash Equivalents And Short Term Investments: 103745000.00
CGEN balance_sheet (quarterly, 2025-03-31) — Common Stock Equity: 57108000.00
CGEN income_statement (quarterly, 2025-03-31) — Cost Of Revenue: 2400000.00
CGEN balance_sheet (quarterly, 2025-03-31) — Current Assets: 106893000.00
CGEN balance_sheet (quarterly, 2025-03-31) — Current Capital Lease Obligation: 423000.00
CGEN balance_sheet (quarterly, 2025-03-31) — Current Debt And Capital Lease Obligation: 423000.00
CGEN balance_sheet (quarterly, 2025-03-31) — Current Deferred Liabilities: 9626000.00
CGEN balance_sheet (quarterly, 2025-03-31) — Current Deferred Revenue: 9626000.00
CGEN balance_sheet (quarterly, 2025-03-31) — Current Liabilities: 20993000.00
CGEN balance_sheet (quarterly, 2025-03-31) — Defined Pension Benefit: 2870000.00
CGEN income_statement (quarterly, 2025-03-31) — Diluted Average Shares: 92308225.00
CGEN income_statement (quarterly, 2025-03-31) — Diluted EPS: -0.08
CGEN income_statement (quarterly, 2025-03-31) — Diluted NI Availto Com Stockholders: -7181000.00
CGEN income_statement (quarterly, 2025-03-31) — EBIT: -8395000.00
CGEN income_statement (quarterly, 2025-03-31) — EBITDA: -8395000.00
CGEN balance_sheet (quarterly, 2025-03-31) — Employee Benefits: 3227000.00
CGEN income_statement (quarterly, 2025-03-31) — General And Administrative Expense: 2367000.00
CGEN balance_sheet (quarterly, 2025-03-31) — Gross PPE: 3708000.00
CGEN income_statement (quarterly, 2025-03-31) — Gross Profit: -116000.00
CGEN balance_sheet (quarterly, 2025-03-31) — Long Term Capital Lease Obligation: 2348000.00
CGEN balance_sheet (quarterly, 2025-03-31) — Long Term Debt And Capital Lease Obligation: 2348000.00
CGEN income_statement (quarterly, 2025-03-31) — Net Income: -7181000.00
CGEN income_statement (quarterly, 2025-03-31) — Net Income Common Stockholders: -7181000.00
CGEN income_statement (quarterly, 2025-03-31) — Net Income Continuous Operations: -7181000.00
CGEN income_statement (quarterly, 2025-03-31) — Net Income From Continuing And Discontinued Operation: -7181000.00
CGEN income_statement (quarterly, 2025-03-31) — Net Income From Continuing Operation Net Minority Interest: -7181000.00
CGEN income_statement (quarterly, 2025-03-31) — Net Income Including Noncontrolling Interests: -7181000.00
CGEN income_statement (quarterly, 2025-03-31) — Net Interest Income: 1245000.00
CGEN income_statement (quarterly, 2025-03-31) — Net Non Operating Interest Income Expense: 1245000.00
CGEN balance_sheet (quarterly, 2025-03-31) — Net PPE: 3708000.00
CGEN balance_sheet (quarterly, 2025-03-31) — Net Tangible Assets: 57108000.00
CGEN balance_sheet (quarterly, 2025-03-31) — Non Current Deferred Liabilities: 31767000.00
CGEN balance_sheet (quarterly, 2025-03-31) — Non Current Deferred Revenue: 31767000.00
CGEN balance_sheet (quarterly, 2025-03-31) — Non Current Pension And Other Postretirement Benefit Plans: 3227000.00
CGEN balance_sheet (quarterly, 2025-03-31) — Non Current Prepaid Assets: 1636000.00
CGEN income_statement (quarterly, 2025-03-31) — Normalized EBITDA: -8395000.00
CGEN income_statement (quarterly, 2025-03-31) — Normalized Income: -7181000.00
CGEN income_statement (quarterly, 2025-03-31) — Operating Income: -8395000.00
CGEN income_statement (quarterly, 2025-03-31) — Operating Revenue: 2284000.00
CGEN balance_sheet (quarterly, 2025-03-31) — Ordinary Shares Number: 93512982.00
CGEN income_statement (quarterly, 2025-03-31) — Other Gand A: 2367000.00
CGEN balance_sheet (quarterly, 2025-03-31) — Other Non Current Assets: 336000.00
CGEN balance_sheet (quarterly, 2025-03-31) — Other Properties: 3708000.00
CGEN balance_sheet (quarterly, 2025-03-31) — Other Receivables: 3148000.00
CGEN balance_sheet (quarterly, 2025-03-31) — Other Short Term Investments: 89170000.00
CGEN balance_sheet (quarterly, 2025-03-31) — Payables And Accrued Expenses: 10944000.00
CGEN income_statement (quarterly, 2025-03-31) — Pretax Income: -7150000.00
CGEN balance_sheet (quarterly, 2025-03-31) — Receivables: 3148000.00
CGEN income_statement (quarterly, 2025-03-31) — Reconciled Cost Of Revenue: 2400000.00
CGEN income_statement (quarterly, 2025-03-31) — Research And Development: 5773000.00
CGEN income_statement (quarterly, 2025-03-31) — Selling And Marketing Expense: 139000.00
CGEN income_statement (quarterly, 2025-03-31) — Selling General And Administration: 2506000.00
CGEN balance_sheet (quarterly, 2025-03-31) — Share Issued: 93512982.00
CGEN balance_sheet (quarterly, 2025-03-31) — Stockholders Equity: 57108000.00
CGEN balance_sheet (quarterly, 2025-03-31) — Tangible Book Value: 57108000.00
CGEN income_statement (quarterly, 2025-03-31) — Tax Effect Of Unusual Items: 0.00
CGEN income_statement (quarterly, 2025-03-31) — Tax Provision: 31000.00
CGEN income_statement (quarterly, 2025-03-31) — Tax Rate For Calcs: 0.23
CGEN balance_sheet (quarterly, 2025-03-31) — Total Assets: 115443000.00
CGEN balance_sheet (quarterly, 2025-03-31) — Total Capitalization: 57108000.00
CGEN balance_sheet (quarterly, 2025-03-31) — Total Debt: 2771000.00
CGEN balance_sheet (quarterly, 2025-03-31) — Total Equity Gross Minority Interest: 57108000.00
CGEN income_statement (quarterly, 2025-03-31) — Total Expenses: 10679000.00
CGEN balance_sheet (quarterly, 2025-03-31) — Total Liabilities Net Minority Interest: 58335000.00
CGEN balance_sheet (quarterly, 2025-03-31) — Total Non Current Assets: 8550000.00
CGEN balance_sheet (quarterly, 2025-03-31) — Total Non Current Liabilities Net Minority Interest: 37342000.00
CGEN income_statement (quarterly, 2025-03-31) — Total Operating Income As Reported: -8395000.00
CGEN income_statement (quarterly, 2025-03-31) — Total Other Finance Cost: -1245000.00
CGEN balance_sheet (quarterly, 2025-03-31) — Working Capital: 85900000.00
CGEN income_statement (quarterly, 2025-06-30) — +Operating Expense: 8021000.00
CGEN income_statement (quarterly, 2025-06-30) — +Total Revenue: 1257000.00
CGEN income_statement (quarterly, 2025-06-30) — Basic Average Shares: 93526884.00
CGEN income_statement (quarterly, 2025-06-30) — Basic EPS: -0.08
CGEN balance_sheet (quarterly, 2025-06-30) — Capital Lease Obligations: 2970000.00
CGEN balance_sheet (quarterly, 2025-06-30) — Cash And Cash Equivalents: 6467000.00
CGEN balance_sheet (quarterly, 2025-06-30) — Cash Cash Equivalents And Short Term Investments: 93877000.00
CGEN balance_sheet (quarterly, 2025-06-30) — Common Stock Equity: 50256000.00
CGEN income_statement (quarterly, 2025-06-30) — Cost Of Revenue: 1665000.00
CGEN balance_sheet (quarterly, 2025-06-30) — Current Assets: 97642000.00
CGEN balance_sheet (quarterly, 2025-06-30) — Current Capital Lease Obligation: 471000.00
CGEN balance_sheet (quarterly, 2025-06-30) — Current Debt And Capital Lease Obligation: 471000.00
CGEN balance_sheet (quarterly, 2025-06-30) — Current Deferred Liabilities: 10545000.00
CGEN balance_sheet (quarterly, 2025-06-30) — Current Deferred Revenue: 10545000.00
CGEN balance_sheet (quarterly, 2025-06-30) — Current Liabilities: 20583000.00
CGEN balance_sheet (quarterly, 2025-06-30) — Defined Pension Benefit: 3257000.00
CGEN income_statement (quarterly, 2025-06-30) — Diluted Average Shares: 93526884.00
CGEN income_statement (quarterly, 2025-06-30) — Diluted EPS: -0.08
CGEN income_statement (quarterly, 2025-06-30) — Diluted NI Availto Com Stockholders: -7342000.00
CGEN income_statement (quarterly, 2025-06-30) — EBIT: -8429000.00
CGEN income_statement (quarterly, 2025-06-30) — EBITDA: -8429000.00
CGEN balance_sheet (quarterly, 2025-06-30) — Employee Benefits: 3595000.00
CGEN income_statement (quarterly, 2025-06-30) — General And Administrative Expense: 2239000.00
CGEN balance_sheet (quarterly, 2025-06-30) — Gross PPE: 3517000.00
CGEN income_statement (quarterly, 2025-06-30) — Gross Profit: -408000.00
CGEN income_statement (quarterly, 2025-06-30) — Interest Income: 1070000.00
CGEN income_statement (quarterly, 2025-06-30) — Interest Income Non Operating: 1070000.00
CGEN balance_sheet (quarterly, 2025-06-30) — Long Term Capital Lease Obligation: 2499000.00
CGEN balance_sheet (quarterly, 2025-06-30) — Long Term Debt And Capital Lease Obligation: 2499000.00
CGEN income_statement (quarterly, 2025-06-30) — Net Income: -7342000.00
CGEN income_statement (quarterly, 2025-06-30) — Net Income Common Stockholders: -7342000.00
CGEN income_statement (quarterly, 2025-06-30) — Net Income Continuous Operations: -7342000.00
CGEN income_statement (quarterly, 2025-06-30) — Net Income From Continuing And Discontinued Operation: -7342000.00
CGEN income_statement (quarterly, 2025-06-30) — Net Income From Continuing Operation Net Minority Interest: -7342000.00
CGEN income_statement (quarterly, 2025-06-30) — Net Income Including Noncontrolling Interests: -7342000.00
CGEN income_statement (quarterly, 2025-06-30) — Net Interest Income: 1070000.00
CGEN income_statement (quarterly, 2025-06-30) — Net Non Operating Interest Income Expense: 1070000.00
CGEN balance_sheet (quarterly, 2025-06-30) — Net PPE: 3517000.00
CGEN balance_sheet (quarterly, 2025-06-30) — Net Tangible Assets: 50256000.00
CGEN balance_sheet (quarterly, 2025-06-30) — Non Current Deferred Liabilities: 29592000.00
CGEN balance_sheet (quarterly, 2025-06-30) — Non Current Deferred Revenue: 29592000.00
CGEN balance_sheet (quarterly, 2025-06-30) — Non Current Pension And Other Postretirement Benefit Plans: 3595000.00
CGEN balance_sheet (quarterly, 2025-06-30) — Non Current Prepaid Assets: 1738000.00
CGEN income_statement (quarterly, 2025-06-30) — Normalized EBITDA: -8429000.00
CGEN income_statement (quarterly, 2025-06-30) — Normalized Income: -7342000.00
CGEN income_statement (quarterly, 2025-06-30) — Operating Income: -8429000.00
CGEN income_statement (quarterly, 2025-06-30) — Operating Revenue: 1257000.00
CGEN balance_sheet (quarterly, 2025-06-30) — Ordinary Shares Number: 93535357.00
CGEN income_statement (quarterly, 2025-06-30) — Other Gand A: 2239000.00
CGEN balance_sheet (quarterly, 2025-06-30) — Other Non Current Assets: 371000.00
CGEN balance_sheet (quarterly, 2025-06-30) — Other Properties: 3517000.00
CGEN balance_sheet (quarterly, 2025-06-30) — Other Receivables: 3765000.00
CGEN balance_sheet (quarterly, 2025-06-30) — Other Short Term Investments: 87410000.00
CGEN balance_sheet (quarterly, 2025-06-30) — Payables And Accrued Expenses: 9567000.00
CGEN income_statement (quarterly, 2025-06-30) — Pretax Income: -7359000.00
CGEN balance_sheet (quarterly, 2025-06-30) — Receivables: 3765000.00
CGEN income_statement (quarterly, 2025-06-30) — Reconciled Cost Of Revenue: 1665000.00
CGEN income_statement (quarterly, 2025-06-30) — Research And Development: 5641000.00
CGEN income_statement (quarterly, 2025-06-30) — Selling And Marketing Expense: 141000.00
CGEN income_statement (quarterly, 2025-06-30) — Selling General And Administration: 2380000.00
CGEN balance_sheet (quarterly, 2025-06-30) — Share Issued: 93535357.00
CGEN balance_sheet (quarterly, 2025-06-30) — Stockholders Equity: 50256000.00
CGEN balance_sheet (quarterly, 2025-06-30) — Tangible Book Value: 50256000.00
CGEN income_statement (quarterly, 2025-06-30) — Tax Effect Of Unusual Items: 0.00
CGEN income_statement (quarterly, 2025-06-30) — Tax Provision: -17000.00
CGEN income_statement (quarterly, 2025-06-30) — Tax Rate For Calcs: 0.00
CGEN balance_sheet (quarterly, 2025-06-30) — Total Assets: 106525000.00
CGEN balance_sheet (quarterly, 2025-06-30) — Total Capitalization: 50256000.00
CGEN balance_sheet (quarterly, 2025-06-30) — Total Debt: 2970000.00
CGEN balance_sheet (quarterly, 2025-06-30) — Total Equity Gross Minority Interest: 50256000.00
CGEN income_statement (quarterly, 2025-06-30) — Total Expenses: 9686000.00
CGEN balance_sheet (quarterly, 2025-06-30) — Total Liabilities Net Minority Interest: 56269000.00
CGEN balance_sheet (quarterly, 2025-06-30) — Total Non Current Assets: 8883000.00
CGEN balance_sheet (quarterly, 2025-06-30) — Total Non Current Liabilities Net Minority Interest: 35686000.00
CGEN income_statement (quarterly, 2025-06-30) — Total Operating Income As Reported: -8429000.00
CGEN balance_sheet (quarterly, 2025-06-30) — Working Capital: 77059000.00
CGEN income_statement (quarterly, 2025-09-30) — +Operating Expense: 8134000.00
CGEN income_statement (quarterly, 2025-09-30) — +Total Revenue: 1891000.00
CGEN income_statement (quarterly, 2025-09-30) — Basic Average Shares: 93538565.00
CGEN income_statement (quarterly, 2025-09-30) — Basic EPS: -0.07
CGEN balance_sheet (quarterly, 2025-09-30) — Capital Lease Obligations: 2946000.00
CGEN balance_sheet (quarterly, 2025-09-30) — Cash And Cash Equivalents: 7455000.00
CGEN balance_sheet (quarterly, 2025-09-30) — Cash Cash Equivalents And Short Term Investments: 86088000.00
CGEN balance_sheet (quarterly, 2025-09-30) — Common Stock Equity: 43826000.00
CGEN income_statement (quarterly, 2025-09-30) — Cost Of Revenue: 1650000.00
CGEN balance_sheet (quarterly, 2025-09-30) — Current Assets: 88920000.00
CGEN balance_sheet (quarterly, 2025-09-30) — Current Capital Lease Obligation: 486000.00
CGEN balance_sheet (quarterly, 2025-09-30) — Current Debt And Capital Lease Obligation: 486000.00
CGEN balance_sheet (quarterly, 2025-09-30) — Current Deferred Liabilities: 10675000.00
CGEN balance_sheet (quarterly, 2025-09-30) — Current Deferred Revenue: 10675000.00
CGEN balance_sheet (quarterly, 2025-09-30) — Current Liabilities: 20283000.00
CGEN balance_sheet (quarterly, 2025-09-30) — Defined Pension Benefit: 3418000.00
CGEN income_statement (quarterly, 2025-09-30) — Diluted Average Shares: 93538565.00
CGEN income_statement (quarterly, 2025-09-30) — Diluted EPS: -0.07
CGEN income_statement (quarterly, 2025-09-30) — Diluted NI Availto Com Stockholders: -6979000.00
CGEN income_statement (quarterly, 2025-09-30) — EBIT: -7893000.00
CGEN income_statement (quarterly, 2025-09-30) — EBITDA: -7893000.00
CGEN balance_sheet (quarterly, 2025-09-30) — Employee Benefits: 3705000.00
CGEN income_statement (quarterly, 2025-09-30) — General And Administrative Expense: 2195000.00
CGEN balance_sheet (quarterly, 2025-09-30) — Gross PPE: 3379000.00
CGEN income_statement (quarterly, 2025-09-30) — Gross Profit: 241000.00
CGEN income_statement (quarterly, 2025-09-30) — Interest Income: 954000.00
CGEN income_statement (quarterly, 2025-09-30) — Interest Income Non Operating: 954000.00
CGEN balance_sheet (quarterly, 2025-09-30) — Long Term Capital Lease Obligation: 2460000.00
CGEN balance_sheet (quarterly, 2025-09-30) — Long Term Debt And Capital Lease Obligation: 2460000.00
CGEN income_statement (quarterly, 2025-09-30) — Net Income: -6979000.00
CGEN income_statement (quarterly, 2025-09-30) — Net Income Common Stockholders: -6979000.00
CGEN income_statement (quarterly, 2025-09-30) — Net Income Continuous Operations: -6979000.00
CGEN income_statement (quarterly, 2025-09-30) — Net Income From Continuing And Discontinued Operation: -6979000.00
CGEN income_statement (quarterly, 2025-09-30) — Net Income From Continuing Operation Net Minority Interest: -6979000.00
CGEN income_statement (quarterly, 2025-09-30) — Net Income Including Noncontrolling Interests: -6979000.00
CGEN income_statement (quarterly, 2025-09-30) — Net Interest Income: 954000.00
CGEN income_statement (quarterly, 2025-09-30) — Net Non Operating Interest Income Expense: 954000.00
CGEN balance_sheet (quarterly, 2025-09-30) — Net PPE: 3379000.00
CGEN balance_sheet (quarterly, 2025-09-30) — Net Tangible Assets: 43826000.00
CGEN balance_sheet (quarterly, 2025-09-30) — Non Current Deferred Liabilities: 27571000.00
CGEN balance_sheet (quarterly, 2025-09-30) — Non Current Deferred Revenue: 27571000.00
CGEN balance_sheet (quarterly, 2025-09-30) — Non Current Pension And Other Postretirement Benefit Plans: 3705000.00
CGEN balance_sheet (quarterly, 2025-09-30) — Non Current Prepaid Assets: 1734000.00
CGEN income_statement (quarterly, 2025-09-30) — Normalized EBITDA: -7893000.00
CGEN income_statement (quarterly, 2025-09-30) — Normalized Income: -6979000.00
CGEN income_statement (quarterly, 2025-09-30) — Operating Income: -7893000.00
CGEN income_statement (quarterly, 2025-09-30) — Operating Revenue: 1891000.00
CGEN balance_sheet (quarterly, 2025-09-30) — Ordinary Shares Number: 93535357.00
CGEN income_statement (quarterly, 2025-09-30) — Other Gand A: 2195000.00
CGEN balance_sheet (quarterly, 2025-09-30) — Other Non Current Assets: 394000.00
CGEN balance_sheet (quarterly, 2025-09-30) — Other Properties: 3379000.00
CGEN balance_sheet (quarterly, 2025-09-30) — Other Receivables: 2832000.00
CGEN balance_sheet (quarterly, 2025-09-30) — Other Short Term Investments: 78633000.00
CGEN balance_sheet (quarterly, 2025-09-30) — Payables And Accrued Expenses: 9122000.00
CGEN income_statement (quarterly, 2025-09-30) — Pretax Income: -6939000.00
CGEN balance_sheet (quarterly, 2025-09-30) — Receivables: 2832000.00
CGEN income_statement (quarterly, 2025-09-30) — Reconciled Cost Of Revenue: 1650000.00
CGEN income_statement (quarterly, 2025-09-30) — Research And Development: 5800000.00
CGEN income_statement (quarterly, 2025-09-30) — Selling And Marketing Expense: 139000.00
CGEN income_statement (quarterly, 2025-09-30) — Selling General And Administration: 2334000.00
CGEN balance_sheet (quarterly, 2025-09-30) — Share Issued: 93535357.00
CGEN balance_sheet (quarterly, 2025-09-30) — Stockholders Equity: 43826000.00
CGEN balance_sheet (quarterly, 2025-09-30) — Tangible Book Value: 43826000.00
CGEN income_statement (quarterly, 2025-09-30) — Tax Effect Of Unusual Items: 0.00
CGEN income_statement (quarterly, 2025-09-30) — Tax Provision: 40000.00
CGEN income_statement (quarterly, 2025-09-30) — Tax Rate For Calcs: 0.23
CGEN balance_sheet (quarterly, 2025-09-30) — Total Assets: 97845000.00
CGEN balance_sheet (quarterly, 2025-09-30) — Total Capitalization: 43826000.00
CGEN balance_sheet (quarterly, 2025-09-30) — Total Debt: 2946000.00
CGEN balance_sheet (quarterly, 2025-09-30) — Total Equity Gross Minority Interest: 43826000.00
CGEN income_statement (quarterly, 2025-09-30) — Total Expenses: 9784000.00
CGEN balance_sheet (quarterly, 2025-09-30) — Total Liabilities Net Minority Interest: 54019000.00
CGEN balance_sheet (quarterly, 2025-09-30) — Total Non Current Assets: 8925000.00
CGEN balance_sheet (quarterly, 2025-09-30) — Total Non Current Liabilities Net Minority Interest: 33736000.00
CGEN income_statement (quarterly, 2025-09-30) — Total Operating Income As Reported: -7893000.00
CGEN balance_sheet (quarterly, 2025-09-30) — Working Capital: 68637000.00
CGEN income_statement (annual, 2025-12-31) — +Operating Expense: 32187000.00
CGEN income_statement (quarterly, 2025-12-31) — +Operating Expense: 7753000.00
CGEN income_statement (annual, 2025-12-31) — +Total Revenue: 2327033.16
CGEN income_statement (quarterly, 2025-12-31) — +Total Revenue: 2153314.78
CGEN balance_sheet (annual, 2025-12-31) — Accounts Payable: 2353000.00
CGEN balance_sheet (quarterly, 2025-12-31) — Accounts Payable: 2353000.00
CGEN balance_sheet (annual, 2025-12-31) — Accumulated Depreciation: -6219000.00
CGEN balance_sheet (quarterly, 2025-12-31) — Accumulated Depreciation: -6219000.00
CGEN balance_sheet (annual, 2025-12-31) — Additional Paid In Capital: 555876000.00
CGEN balance_sheet (quarterly, 2025-12-31) — Additional Paid In Capital: 555876000.00
CGEN income_statement (annual, 2025-12-31) — Basic Average Shares: 93425341.00
CGEN income_statement (quarterly, 2025-12-31) — Basic Average Shares: 94304508.00
CGEN income_statement (annual, 2025-12-31) — Basic EPS: 0.38
CGEN income_statement (quarterly, 2025-12-31) — Basic EPS: 0.60
CGEN cash_flow (annual, 2025-12-31) — Beginning Cash Position: 18229000.00
CGEN cash_flow (annual, 2025-12-31) — Capital Expenditure: -306000.00
CGEN balance_sheet (annual, 2025-12-31) — Capital Lease Obligations: 2960000.00
CGEN balance_sheet (quarterly, 2025-12-31) — Capital Lease Obligations: 2960000.00
CGEN balance_sheet (annual, 2025-12-31) — Capital Stock: 262000.00
CGEN balance_sheet (quarterly, 2025-12-31) — Capital Stock: 262000.00
CGEN balance_sheet (annual, 2025-12-31) — Cash And Cash Equivalents: 90597000.00
CGEN balance_sheet (quarterly, 2025-12-31) — Cash And Cash Equivalents: 90597000.00
CGEN balance_sheet (annual, 2025-12-31) — Cash Cash Equivalents And Short Term Investments: 145640000.00
CGEN balance_sheet (quarterly, 2025-12-31) — Cash Cash Equivalents And Short Term Investments: 145640000.00
CGEN cash_flow (annual, 2025-12-31) — Cash Flow From Continuing Financing Activities: 10604000.00
CGEN cash_flow (annual, 2025-12-31) — Cash Flow From Continuing Investing Activities: 29995000.00
CGEN cash_flow (annual, 2025-12-31) — Cash Flow From Continuing Operating Activities: 31634000.00
CGEN cash_flow (annual, 2025-12-31) — Change In Account Payable: 517000.00
CGEN cash_flow (annual, 2025-12-31) — Change In Accrued Expense: 500000.00
CGEN cash_flow (annual, 2025-12-31) — Change In Other Current Assets: 479000.00
CGEN cash_flow (annual, 2025-12-31) — Change In Other Current Liabilities: -109000.00
CGEN cash_flow (annual, 2025-12-31) — Change In Other Working Capital: -7788000.00
CGEN cash_flow (annual, 2025-12-31) — Change In Payable: 517000.00
CGEN cash_flow (annual, 2025-12-31) — Change In Payables And Accrued Expense: 1017000.00
CGEN cash_flow (annual, 2025-12-31) — Change In Prepaid Assets: 595000.00
CGEN cash_flow (annual, 2025-12-31) — Change In Receivables: 458000.00
CGEN cash_flow (annual, 2025-12-31) — Change In Working Capital: -5348000.00
CGEN cash_flow (annual, 2025-12-31) — Changes In Account Receivables: 0.00
CGEN cash_flow (annual, 2025-12-31) — Changes In Cash: 72233000.00
CGEN balance_sheet (annual, 2025-12-31) — Common Stock: 262000.00
CGEN balance_sheet (quarterly, 2025-12-31) — Common Stock: 262000.00
CGEN balance_sheet (annual, 2025-12-31) — Common Stock Equity: 102731000.00
CGEN balance_sheet (quarterly, 2025-12-31) — Common Stock Equity: 102731000.00
CGEN cash_flow (annual, 2025-12-31) — Common Stock Issuance: 10535000.00
CGEN income_statement (annual, 2025-12-31) — Cost Of Revenue: 9251000.00
CGEN income_statement (quarterly, 2025-12-31) — Cost Of Revenue: 3536000.00
CGEN balance_sheet (annual, 2025-12-31) — Current Accrued Expenses: 5676000.00
CGEN balance_sheet (quarterly, 2025-12-31) — Current Accrued Expenses: 5676000.00
CGEN balance_sheet (annual, 2025-12-31) — Current Assets: 148022000.00
CGEN balance_sheet (quarterly, 2025-12-31) — Current Assets: 148022000.00
CGEN balance_sheet (annual, 2025-12-31) — Current Capital Lease Obligation: 521000.00
CGEN balance_sheet (quarterly, 2025-12-31) — Current Capital Lease Obligation: 521000.00
CGEN balance_sheet (annual, 2025-12-31) — Current Debt And Capital Lease Obligation: 521000.00
CGEN balance_sheet (quarterly, 2025-12-31) — Current Debt And Capital Lease Obligation: 521000.00
CGEN balance_sheet (annual, 2025-12-31) — Current Deferred Liabilities: 10970000.00
CGEN balance_sheet (quarterly, 2025-12-31) — Current Deferred Liabilities: 10970000.00
CGEN balance_sheet (annual, 2025-12-31) — Current Deferred Revenue: 10970000.00
CGEN balance_sheet (quarterly, 2025-12-31) — Current Deferred Revenue: 10970000.00
CGEN balance_sheet (annual, 2025-12-31) — Current Liabilities: 22570000.00
CGEN balance_sheet (quarterly, 2025-12-31) — Current Liabilities: 22570000.00
CGEN balance_sheet (annual, 2025-12-31) — Defined Pension Benefit: 3643000.00
CGEN balance_sheet (quarterly, 2025-12-31) — Defined Pension Benefit: 3643000.00
CGEN cash_flow (annual, 2025-12-31) — Depreciation: 475000.00
CGEN cash_flow (annual, 2025-12-31) — Depreciation Amortization Depletion: 475000.00
CGEN cash_flow (annual, 2025-12-31) — Depreciation And Amortization: 475000.00
CGEN income_statement (annual, 2025-12-31) — Diluted Average Shares: 93815083.00
CGEN income_statement (quarterly, 2025-12-31) — Diluted Average Shares: 94712039.00
CGEN income_statement (annual, 2025-12-31) — Diluted EPS: 0.38
CGEN income_statement (quarterly, 2025-12-31) — Diluted EPS: 0.60
CGEN income_statement (annual, 2025-12-31) — Diluted NI Availto Com Stockholders: 35343000.00
CGEN income_statement (quarterly, 2025-12-31) — Diluted NI Availto Com Stockholders: 56845000.00
CGEN income_statement (annual, 2025-12-31) — EBIT: 31326000.00
CGEN income_statement (quarterly, 2025-12-31) — EBIT: 56043000.00